Benchling Convenes Global Community of R&D Scientists and Technology Leaders at Benchtalk

We're building an AI Scientist, designed to get molecules to the clinic twice as fast. Read the blog
English

Press Releases

Benchling Convenes Global Community of R&D Scientists and Technology Leaders at Benchtalk

Bristol Myers Squibb, Eli Lilly, FogPharma, Merck, Sanofi, Spark Therapeutics, and Tango Therapeutics share strategies for digital innovation in the lab

San Francisco, CA and Boston, MA. August 27, 2024.  Benchling, the R&D Cloud powering the biotech industry, announced the full agenda and speaker lineup for Benchtalk, its annual industry conference taking place on October 1-2 in Boston. Benchtalk brings together key players in the tech-driven life sciences ecosystem, including R&D scientists, IT leaders, data scientists, and developers. Attendees will explore strategies on the topics shaping the future of biotech, from AI/ML integration and data governance to lab automation and scaling digital infrastructure.

This year’s two-day event features sessions led by top biotech and biopharma companies, including the following highlights:  

  • Eli Lilly, advancing AI/ML through a focus on data quality. 

  • Merck and Sanofi, driving a modern IT strategy to enhance data governance and digital transformation.  

  • Bristol Myers Squibb, customizing tools to fit your science with practical tips from a developer’s journey.

  • MacroGenics, unifying process development workflows to meet the new scale and demands on development.

  • Tango Therapeutics, leveraging advancements in data visualization and reporting to turn data into actionable insights.  

  • Leading early-stage biotech companies, navigating through scientific, personnel, and technical uncertainty to achieve successful system adoption. 

Benchling CEO Sajith Wickramasekara will kick off the event with a keynote, presenting an exclusive first-look demo of the new Benchling Notebook and showcasing the latest advancements in the Benchling R&D Cloud. The agenda features a fireside chat with Matthai Mammen, CEO, Chairman, and President of FogPharma and former EVP of Pharmaceuticals R&D at Johnson & Johnson. Attendees can also take advantage of technical hands-on training, industry-specific breakout sessions, and networking.

Registration

Benchtalk takes place at Westin Copley Place in Boston on October 1 -2. Early registration is highly recommended to secure your spot. For more details and to register, visit https://benchtalk.benchling.com/boston24.

For Benchling’s European community, Benchtalk is coming to London on October 23-24. To register and learn more about the event’s speakers and content lineup, visit https://benchtalk.benchling.com/london24. 

Drift Widget
📊 See how your AI adoption compares to 100+ biotech companies with a quick benchmark quiz. Let's ge...
1